We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
-2.5%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$371B
AUM Growth
-$10.1B
Cap. Flow
+$3.4B
Cap. Flow %
0.92%
Top 10 Hldgs %
14.14%
Holding
3,966
New
118
Increased
2,175
Reduced
1,355
Closed
98

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$467M
2
CRH icon
CRH
CRH
+$449M
3
AVGO icon
Broadcom
AVGO
+$446M
4
PM icon
Philip Morris
PM
+$414M
5
KVUE icon
Kenvue
KVUE
+$347M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$494M
2
XOM icon
ExxonMobil
XOM
+$443M
3
V icon
Visa
V
+$433M
4
MRK icon
Merck
MRK
+$402M
5
AMD icon
Advanced Micro Devices
AMD
+$388M

Sector Composition

Rank Sector Weight
1 Technology 21.89%
2 Healthcare 11.83%
3 Financials 11.72%
4 Industrials 11.2%
5 Consumer Discretionary 10.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRGE
3701
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$26.7K ﹤0.01%
53,703
TGAN
3702
DELISTED
Transphorm, Inc. Common Stock
TGAN
$26.4K ﹤0.01%
11,914
SCLX icon
3703
Scilex Holding
SCLX
$46.1M
$26.4K ﹤0.01%
538
-14
-3% -$1.92K
ORMP icon
3704
Oramed Pharmaceuticals
ORMP
$162M
$26.3K ﹤0.01%
+10,094
New +$31.8K
ZVIA icon
3705
Zevia
ZVIA
$118M
$25.3K ﹤0.01%
11,401
KLRS
3706
Kalaris Therapeutics
KLRS
$80.9M
$24.8K ﹤0.01%
501
+36
+8% +$2.45K
AUTL
3707
Autolus Therapeutics
AUTL
$389M
$24K ﹤0.01%
10,314
-385
-4% -$1.1K
PIII icon
3708
P3 Health Partners
PIII
$34.9M
$23.9K ﹤0.01%
325
ARVL
3709
DELISTED
Arrival Ordinary Shares
ARVL
$23.2K ﹤0.01%
19,521
+144
+0.7% +$257
CRVS icon
3710
Corvus Pharmaceuticals
CRVS
$1.1B
$22.8K ﹤0.01%
15,617
+4,672
+43% +$9.88K
SLGL icon
3711
Sol-Gel Technologies
SLGL
$270M
$22.2K ﹤0.01%
+1,363
New +$39.3K
ESPR
3712
DELISTED
Esperion Therapeutics
ESPR
$22K ﹤0.01%
22,495
-3,454
-13% -$5K
AEVA
3713
Aeva Technologies
AEVA
$956M
$20.9K ﹤0.01%
5,465
BBAI icon
3714
BigBear.ai
BBAI
$1.24B
$20.7K ﹤0.01%
13,713
MKTW icon
3715
MarketWise
MKTW
$54.6M
$19.7K ﹤0.01%
615
+105
+21% +$3.56K
KZR
3716
DELISTED
Kezar Life Sciences
KZR
$18.2K ﹤0.01%
1,531
+191
+14% +$3.38K
AKTS
3717
DELISTED
Akoustis Technologies Inc
AKTS
$17.6K ﹤0.01%
23,383
RBOT
3718
DELISTED
Vicarious Surgical
RBOT
$16.9K ﹤0.01%
955
AVAH icon
3719
Aveanna Healthcare
AVAH
$2.12B
$15.4K ﹤0.01%
12,975
BGXX
3720
DELISTED
Bright Green Corporation Common Stock
BGXX
$12.2K ﹤0.01%
30,803
LLAP
3721
DELISTED
Terran Orbital Corporation
LLAP
$11.7K ﹤0.01%
+14,057
New +$18.6K
OTLK icon
3722
Outlook Therapeutics
OTLK
$187M
$11.2K ﹤0.01%
2,526
LPTV
3723
DELISTED
Loop Media, Inc.
LPTV
$9.25K ﹤0.01%
18,616
GOEV
3724
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$6.61K ﹤0.01%
+29
New +$7.31K
NUTX
3725
Nutex Health
NUTX
$967M
$2.19K ﹤0.01%
72

Similar funds

Invesco's Q3 2023 Portfolio in Review

As of Q3 2023, Invesco held 3,966 positions worth $371B, down 2.7% from $381B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Invesco's Q3 2023 filing shows 118 new, 2,175 increased, 1,355 reduced and 98 closed positions. Its largest new stake was Stellantis: 12,130,006 shares worth $232M. The largest sale was Microsoft, an estimated $494M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Invesco's largest Q3 2023 buy was Stellantis: 12,130,006 shares worth $232M.
  • Invesco added most to Adobe in Q3 2023, an estimated $467M increase.
  • Invesco's biggest Q3 2023 reduction was Microsoft, cutting an estimated $494M.
  • Invesco fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $272M.
  • Invesco's ten largest holdings make up 14% of its $371B portfolio in Q3 2023.
  • Invesco opened 118 new positions and closed 98 in Q3 2023.
  • Invesco's portfolio value fell 2.7% quarter-over-quarter to $371B.

Based on Invesco's 13F filing for Q3 2023, filed 13 Nov 2023.